Opus Genetics (IRD) Other Working Capital Changes (2010 - 2026)
Opus Genetics (IRD) reported Other Working Capital Changes of $2.1 million for Q1 2026, up 147.28% year-over-year from $865000.0 in Q1 2025, and up 119.84% quarter-over-quarter from $973000.0 in Q4 2025.
Opus Genetics (IRD) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Opus Genetics (IRD) has 17 years of Other Working Capital Changes data on file, last reported at $2.1 million in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $2.1 million, up 147.28% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 million (up 1207.39% YoY), and the FY2025 annual result was $1.3 million, up 300.79% from the prior year.
- Other Working Capital Changes improved to $2.1 million in Q1 2026 per IRD's latest filing, from $973000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $2.1 million in Q1 2026 and troughed at -$685000.0 in Q3 2024.
- A 5-year average of $171651.9 and a median of $82.0 in 2022 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes tumbled 434246.34% in 2023, then jumped 2602.78% in 2025.
- A 5-year view of Other Working Capital Changes shows it stood at $848000.0 in 2022, then fell by 27.48% to $615000.0 in 2023, then tumbled by 94.15% to $36000.0 in 2024, then jumped by 2602.78% to $973000.0 in 2025, then jumped by 119.84% to $2.1 million in 2026.
- Business Quant data shows IRD's Other Working Capital Changes at $2.1 million in Q1 2026, $973000.0 in Q4 2025, and -$618000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Opus Genetics | 355.39 Mn | 295.43 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.14 Mn |
| Mar 31, 2026 | 2.14 Mn |
| Dec 31, 2025 | 973,000.00 |
| Dec 31, 2025 | 973,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Sep 30, 2025 | -618,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Mar 31, 2025 | 865,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Dec 31, 2024 | 36,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Sep 30, 2024 | -685,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Jun 30, 2024 | -446,000.00 |
| Mar 31, 2024 | 461,000.00 |
| Mar 31, 2024 | 461,000.00 |
| Dec 31, 2023 | 615,000.00 |
| Dec 31, 2023 | 615,000.00 |